The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Calciphylaxis

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Calciphylaxis

 

High impact information on Calciphylaxis

  • Intraarticular calciphylaxis with cartilage and synovial calcification was produced in rabbits by oral administration of a single dose of dehydrotachysterol followed by an intraarticular injection of ferrous chloride [6].
  • Although most calciphylaxis patients have abnormalities of the calcium:phosphate axis or elevated levels of parathyroid hormone, these abnormalities do not appear to be fundamental to the pathophysiology of the disorder, and the etiology of calciphylaxis remains unclear [7].
  • PURPOSE: To determine if the natural anticoagulant protein C plays a role in the pathogenesis of systemic calciphylaxis, a syndrome characterized by extensive vascular and soft tissue calcification and skin necrosis, which is similar to that seen in warfarin-induced skin necrosis [1].
  • However, OPN and MGP were expressed at sites of calcification within atherosclerotic lesions and in microvessels in calciphylaxis, suggesting that calcification in different sized vessels may occur by a common mechanism [8].
  • TSP-1 and COMP were also detected in areas of microcalcification in atherosclerotic lesions and TSP-1 was detected adjacent to areas of calcification in calciphylaxis [8].
 

Chemical compound and disease context of Calciphylaxis

 

Biological context of Calciphylaxis

 

Anatomical context of Calciphylaxis

 

Gene context of Calciphylaxis

  • We present the first case of calciphylaxis occurring in a patient with both normal renal function and parathyroid hormone level and discuss the possible aetiological role of chemotherapy-induced functional protein C and protein S deficiency [20].
  • Protein malnutrition increases the likelihood of calciphylaxis, as does warfarin use and hypercoagulable states, such as protein C and/or protein S deficiency [21].
  • METHODS: We present a case of a 26-year-old woman with end-stage renal disease taking intramuscular injections of erythropoietin in whom systemic calciphylaxis subsequently developed [22].
  • However, protein C activity was significantly reduced as measured by chromogenic (p less than 0.01) or anticoagulant assays (p less than 0.01) in patients with calciphylaxis compared with the other three groups [1].
  • The syndrome has been reviewed in the renal, dermatologic, and surgical literature under the term calciphylaxis, which describes a postulated pathogenetic mechanism whereby sensitization to an endogenous or exogenous substance (such as parathyroid hormone) predisposes to calcium deposition after exposure to a challenging agent [23].
 

Analytical, diagnostic and therapeutic context of Calciphylaxis

References

  1. Skin necrosis associated with acquired protein C deficiency in patients with renal failure and calciphylaxis. Mehta, R.L., Scott, G., Sloand, J.A., Francis, C.W. Am. J. Med. (1990) [Pubmed]
  2. Calciphylaxis in a hemodialysis patient: appearance after parathyroidectomy during a psoriatic flare. Poch, E., Almirall, J., Alsina, M., del Río, R., Cases, A., Revert, L. Am. J. Kidney Dis. (1992) [Pubmed]
  3. Calciphylaxis associated with cholangiocarcinoma treated with low-molecular-weight heparin and vitamin K. Riegert-Johnson, D.L., Kaur, J.S., Pfeifer, E.A. Mayo Clin. Proc. (2001) [Pubmed]
  4. The amino bisphosphonate ibandronate prevents calciphylaxis in the rat at doses that inhibit bone resorption. Price, P.A., Omid, N., Than, T.N., Williamson, M.K. Calcif. Tissue Int. (2002) [Pubmed]
  5. Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis. Brucculeri, M., Cheigh, J., Bauer, G., Serur, D. Seminars in dialysis. (2005) [Pubmed]
  6. Experimental hydroxyapatite synovial and articular cartilage calcification: light and electron microscopic studies. Reginato, A.J., Schumacher, H.R., Brighton, C.T. Arthritis Rheum. (1982) [Pubmed]
  7. Calciphylaxis in chronic renal failure. Budisavljevic, M.N., Cheek, D., Ploth, D.W. J. Am. Soc. Nephrol. (1996) [Pubmed]
  8. The involvement of matrix glycoproteins in vascular calcification and fibrosis: an immunohistochemical study. Canfield, A.E., Farrington, C., Dziobon, M.D., Boot-Handford, R.P., Heagerty, A.M., Kumar, S.N., Roberts, I.S. J. Pathol. (2002) [Pubmed]
  9. Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report. Guerra, G., Shah, R.C., Ross, E.A. Nephrol. Dial. Transplant. (2005) [Pubmed]
  10. Calcergy and calciphylaxis: timed appearance of gamma-carboxyglutamic acid and osteocalcin in mineral deposits. Lian, J.B., Boivin, G., Patterson-Allen, P., Grynpas, M., Walzer, C. Calcif. Tissue Int. (1983) [Pubmed]
  11. Serine phosphate, threonine phosphate and gamma-carboxyglutamic acid in normal and experimentally induced, pathologically calcified rat skin (topical cutaneous calciphylaxis). Glimcher, M.J., Reit, B., Kossiva, D. Calcif. Tissue Int. (1981) [Pubmed]
  12. Calcification of polyurethanes implanted subdermally in rats is enhanced by calciphylaxis. Joshi, R.R., Underwood, T., Frautschi, J.R., Phillips, R.E., Schoen, F.J., Levy, R.J. J. Biomed. Mater. Res. (1996) [Pubmed]
  13. Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure. Monney, P., Nguyen, Q.V., Perroud, H., Descombes, E. Nephrol. Dial. Transplant. (2004) [Pubmed]
  14. Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Mazhar, A.R., Johnson, R.J., Gillen, D., Stivelman, J.C., Ryan, M.J., Davis, C.L., Stehman-Breen, C.O. Kidney Int. (2001) [Pubmed]
  15. Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis). Block, G.A. Curr. Opin. Nephrol. Hypertens. (2001) [Pubmed]
  16. Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism. Girotto, J.A., Harmon, J.W., Ratner, L.E., Nicol, T.L., Wong, L., Chen, H. Surgery (2001) [Pubmed]
  17. Calciphylaxis: seven new cases. Alain, J., Poulin, Y.P., Cloutier, R.A., Gagné, E., Baril, J. Journal of cutaneous medicine and surgery. (2000) [Pubmed]
  18. An unusual presentation of calciphylaxis due to primary hyperparathyroidism. Mirza, I., Chaubay, D., Gunderia, H., Shih, W., El-Fanek, H. Arch. Pathol. Lab. Med. (2001) [Pubmed]
  19. Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis. Griethe, W., Schmitt, R., Jurgensen, J.S., Bachmann, S., Eckardt, K.U., Schindler, R. J. Nephrol. (2003) [Pubmed]
  20. Calciphylaxis in a patient without renal failure or elevated parathyroid hormone: possible aetiological role of chemotherapy. Goyal, S., Huhn, K.M., Provost, T.T. Br. J. Dermatol. (2000) [Pubmed]
  21. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Wilmer, W.A., Magro, C.M. Seminars in dialysis. (2002) [Pubmed]
  22. Systemic calciphylaxis in a patient with end-stage renal disease and a normal parathyroid hormone level taking erythropoietin intramuscularly. Hassaballa, H., Luther, S., Bloom, K.J., Prinz, R.A. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. (1999) [Pubmed]
  23. Calciphylaxis mimicking dermatomyositis: ischemic myopathy complicating renal failure. Flanigan, K.M., Bromberg, M.B., Gregory, M., Baringer, J.R., Jones, C.R., Nester, T.A., Klatt, E.C., Townsend, J.J. Neurology (1998) [Pubmed]
  24. Calciphylaxis in a chronic hemodialysis patient with protein S deficiency. Rostaing, L., el Feki, S., Delisle, M.B., Durand-Malgouyres, C., Ton-That, H., Bonafe, J.L., Bories, P., Durand, D., Suc, J.M. American journal of nephrology. (1995) [Pubmed]
  25. Calciphylaxis: a condition mimicking necrotizing vasculitis. Melikoglu, M., Apaydin, S., Hamuryudan, V., Yurdakul, S., Uygun, N., Aki, H., Ozbay, G., Yazici, H. Clin. Rheumatol. (1996) [Pubmed]
 
WikiGenes - Universities